These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6516213)

  • 1. Results obtained with the NIVGRIP inactivated influenza vaccine applicable by nasal and/or oral route.
    Petrescu AL; Cajal N
    Virologie; 1984; 35(4):307-14. PubMed ID: 6516213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficiency of the NIVGRIP inactivated influenza vaccine applied by oral route: evaluation in a community of pre-school children in the period 1981-84.
    Coban V; Mihail A; Petrescu A; Teodosiu O; Sternberg I
    Virologie; 1985; 36(2):79-83. PubMed ID: 4036003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The experience of the "Stefan S. Nicolau" Institue of Virology in the preparation of administration of inactivated influenza vaccines applicable by nasal or oral route.
    Petrescu A; Cajal N; Broniţki A; Mihail A; Teodosiu O; Popescu G; Isaia G; Popescu A
    Virologie; 1977; 28(3):213-7. PubMed ID: 898654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutralizing influenza antibodies, IgA and total protein in the nasopharyngeal secretions of subjects vaccinated by nasal route with the inactivated influenza vaccine prepared in the "Stefan S. Nicolau" Institute of Virology.
    Petrescu A; Mihail A; Samuel I; Teodosiu O; Isaia G; Ganea E; Motaş C
    Virologie; 1979; 30(2):109-15. PubMed ID: 111408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the oral administration of NIVGRIP inactivated influenza vaccine on virus carriage in the nasopharynx of children aged 0-5 years.
    Isaia G; Teodosiu O; Athanasiu P; Petrescu A; Dumitrescu G
    Virologie; 1985; 36(4):269-72. PubMed ID: 3004017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent influenza vaccination with inactivated vaccines administered by nasal or oral route.
    Petrescu A; Mihail A; Popescu A; Cojiţă M; Sternberg I; Steiner N; Hondor C
    Virologie; 1976; 27(1):41-5. PubMed ID: 941402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of neutralizing secretory influenza antibodies after nasal administration of the NIVGRIP trivalent influenza vaccine.
    Petrescu A; Steiner N; Trăilescu G; Teodosiu O; Mihăilescu M; Berca C
    Virologie; 1985; 36(3):187-94. PubMed ID: 4071977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research on respiratory virus diseases performed in the "Stefan S. Nicolau" Institute of Virology.
    Petrescu A; Broniţki A; Cajal N; Popescu G; Isaia G; Teodosiu O; Mihail A
    Virologie; 1979; 30(4):319-30. PubMed ID: 392913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Complex studies of virology, microbiology, biochemistry and epidemiology in the adults of a semi-closed community vaccinated against influenza with the inactivated NIVGRIP vaccine intranasally].
    Steiner N; Ionită I; Zaharia CN; Petrescu A; Ciocîrlie I; Stafie D; Dicu A; Stanciu A; Muşat G
    Rev Roum Virol; 1992; 43(1-2):47-58. PubMed ID: 1283825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharyngeal viral population in 3- to 6-year-old children before and after influenza immunization using the NIVGRIP vaccine administered orally].
    Pârvu C; Petrescu A; Coban V
    Virologie; 1986; 37(4):263-7. PubMed ID: 3548031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory antibodies in respiratory virus infections.
    Petrescu A
    Virologie; 1984; 35(2):133-8. PubMed ID: 6330974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of neutralizing antibodies in adults after intranasal vaccination with an inactivated influenza vaccine.
    Ainai A; Tamura S; Suzuki T; Ito R; Asanuma H; Tanimoto T; Gomi Y; Manabe S; Ishikawa T; Okuno Y; Odagiri T; Tashiro M; Sata T; Kurata T; Hasegawa H
    J Med Virol; 2012 Feb; 84(2):336-44. PubMed ID: 22170556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization.
    Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN
    J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary data on the efficiency of an inactivated influenza vaccine administered by oral route.
    Cajal N; Sărăteanu D; Petrescu A; Mihail A; Popescu A; Teodosiu O
    Rev Roum Virol (1972); 1974; 25(1):23-7. PubMed ID: 4415167
    [No Abstract]   [Full Text] [Related]  

  • 15. Trivalent live attenuated intranasal influenza vaccine administered during the 2003-2004 influenza type A (H3N2) outbreak provided immediate, direct, and indirect protection in children.
    Piedra PA; Gaglani MJ; Kozinetz CA; Herschler GB; Fewlass C; Harvey D; Zimmerman N; Glezen WP
    Pediatrics; 2007 Sep; 120(3):e553-64. PubMed ID: 17698577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteosome-adjuvanted intranasal influenza vaccines: advantages, progress and future considerations.
    Burt D; Mallett C; Plante M; Zimmermann J; Torossian K; Fries L
    Expert Rev Vaccines; 2011 Mar; 10(3):365-75. PubMed ID: 21434804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.
    Muhamed G; Greenbaum E; Zakay-Rones Z
    Isr Med Assoc J; 2006 Mar; 8(3):155-8. PubMed ID: 16599048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of peroral and intranasal immunization of school children with live allantoic influenza vaccine- and comparative study.
    Koval TA; Aleksandrova GI; Grunis AM; Ivannikov YuG ; Medvedeva TE; Sychev SV; Shaposhnikova RP; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):194-200. PubMed ID: 395255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asthma, influenza, and vaccination.
    Glezen WP
    J Allergy Clin Immunol; 2006 Dec; 118(6):1199-206; quiz 1207-8. PubMed ID: 17157648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of nasal application of inactivated influenza vaccine.
    Fukumi H
    Dev Biol Stand; 1976; 33():155-61. PubMed ID: 782963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.